BPVQQ - KENALOG SPRAY

Product Identification

Product ID:KENALOG SPRAY
MSDS Date:12/04/1991
FSC:6505
NIIN:01-066-1325
MSDS Number: BPVQQ

Responsible Party
WESTWOOD PHARMACEUTICALS INC DIV OF BRISTOL MYERS
100 FOREST AVE
BUFFALO, NY 14213-1032
US

Emergency Phone: 716-887-3440

Info Phone: 716-887-3440

Cage: 13811

Contractor
WESTWOOD PHARMACEUTICALS INC DIV OF BRISTOL MYERS
BUFFALO, NY 14213-1032 US

Telephone: 716-887-3400

Cage: 13811

Ingredients

TRIAMCINOLONE ACETONIDE

CAS: 76-25-5

RTECS: TU3920000

Fraction By Weight: 0.015%


ISOBUTANE

CAS: 75-28-5

RTECS: TZ4300000

Fraction By Weight: 82%

OSHA PEL 1000 PPM

ACGIH TLV: 1000 PPM


ETHYL ALCOHOL (ETHANOL)

CAS: 64-17-5

RTECS: KQ6300000

Fraction By Weight: 10.3%

OSHA PEL 1000 PPM

ACGIH TLV: 1000 PPM; 9293


ISOPROPYL PALMITATE

Fraction By Weight: 7.3%

Hazards

Routes of Entry: Inhalation:YES Skin:YES Ingestion:NO
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:INHALATION-INHALATION EXPOSURE TO
ISOBUTANE MAY PRODUCE ASPHYXIATION, ANESTHESIA & MILD IRRITATION OF
THE MUCOUS MEMBRANES. ORAL-CHANGES IN THE MATRIX OF THE BONES, SKIN
CHANGES, HYPERGLYCEMIA, PEPTIC ULCER, CATARAC DEVELOPMENT,
MENSTRUAL DEVELOPMENT, FLUID & ELECTROLYTE DISTURBANCES.
Explanation of Carcinogenicity:THIS COMPOUND CONTAINS NO INGREDIENTS AT
CONCENTRATIONS OF 0.1% OR GREATER THAT ARE CARCINOGENS OR SUSPECT
CARCINOGENS.
Effects of Overexposure:ORAL-MUSCLE WEAKNESS & FATIGUE, HEADACHE,
VERTIGO. DERMAL-BURNING, ITCHING, IRRITATION, DRYING, CRACKING OR
TIGHTENING OF THE SKIN; THINNING OF THE SKIN; ACNEIFORM ERUPTION;
ERRTHEMA; FOLLICULITIS; HY PERTRICHOSIS; AND OTHER SKIN DISORDERS.
Medical Cond Aggravated by Exposure:THERAPEUTIC DOSES OF GLUCOCORTICOID
MAY AGGRAVATE SYSTEMIC FUNGAL INFECTIONS, TUBERCULOSIS, PEPTIC
ULCERS, DIABETES MELLITUS AND CERTAIN PSYCHIATRIC CONDITIONS.

First Aid

First Aid:EYES CONTACT-FLUSH WITH LARGE AMOUNTS OF WATER FOR 15-20
MINUTES. SKIN CONTACT-WASH WITH SOAP AND WATER FOR 15-20 MINUTES.
INGESTION-GET MEDICAL ATTENTION. INHALATION-REMOVE TO FRESH AIR; IF
DIFFICULT Y INBREATHING ADMINISTER OXYGEN. IF A PERSON IS NOT
BREATHING ARTIFICIAL RESPIRATION CAN BE ATTEMPTED. GET MEDICAL
ATTENTION.

Fire Fighting

Flash Point Method:CC
Flash Point:-117F,-83C
Autoignition Temp:Autoignition Temp Text:UNK
Lower Limits:1.8
Upper Limits:8.4
Extinguishing Media:USE CARBON DIOXIDE OR DRY CHEMICAL. USE WATER TO
KEEP FIRE-EXPOSED CONTAINERS COOL. FIGHT FIRE FROM A SAFE DISTANCE.
Fire Fighting Procedures:EVACUSTE PERSONNEL TO SAFE AREA. A SELF
CONTAINED BREATHING APPARATUS & FULL PROTECTIVE CLOTHING SHOULD BE
WORN BY FIRE FIGHTERS. STOP THE FLOW OF GAS.
Unusual Fire/Explosion Hazard:CARBON DIOXIDE OR DRY CHEMICAL CAN BE
USED TO SMOTHER THE FLAME; HOWEVER, UNLESS THE FLOW OF GAS IS SHUT
OFF, THE GAS CAN BE RE-IGNITED. DIVERT RUNOFF.

Accidental Release

Spill Release Procedures:ELIMINATE ALL SOURCES OF IGNITION. WEARING
SUITABLE PROTECTIVE CLOTHING, STOP LEAK OR REMOVE LEAKY CANISTER TO
SAFE OPEN AREA & VENT SLOWLY TO AIR. IMPERMEABLE GLOVES, EYE
PROTECTION, & A NIOSH-APPROV ED RESPIRATOR SHOULD BE WORN AS A
MINIMUM.
Neutralizing Agent:NA

Handling

Handling and Storage Precautions:STORE & USE IN WELL VENTILATED, LOW
FIRE RISK AREAS, AWAY FROM HEAT & IGNITION SOURCES. STORE AWAY FROM
OXIDIZING AGENTS, INCLUDING, OXYGEN & CHLORINE
Other Precautions:NO SMOKING IN AREAS OF STORAGE OR USE. THERAPUTIC
AGENTS ARE INTENDED FOR USE UNDER DIRECTION OF A PHYSICIAN AND/OR
UNDER THE CONDITIONS OF USE PRESCRIBED ON THE LABEL. PROTECT FROM
HEAT AND SOURCES O F IGNITION.

Exposure Controls

Respiratory Protection:IF IN A MANUFACTURING SETTING, THERE IS A
POTENTIAL FOR INHALATION EXPOSURE, A NIOSH APPROVED RESPIRATOR
SHOULD BE WORN.
Ventilation:NONE SPECIFIED BY MANUFACTURER.
Protective Gloves:WEAR IMPERMEABLE GLOVES.
Eye Protection:WEAR EYE PROTECTION.
Other Protective Equipment:PERSONNEL WHO HANDLE THIS SPRAY IN
AMANUFACTURING FACILITY SHOULD WEAR PROTECTIVE CLOTHING.
Work Hygienic Practices:WASH THOROUGHLY AFTER HANDLING AND BEFORE
EATING, DRINKING OR SMOKING.
Supplemental Safety and Health
AS A GENERAL PRECAUTION, PERSONNEL WHO HANDLE DRUG SUBSTAAANCES SHOULD
AVOID CONTACT (INGESTION, INHALATION, SKIN AND EYE CONTACT) WITH
THESE SUBSTANCES. DOT SHIPPING CLASSIFICATION: FLAMMABLE GAS.

Chemical Properties

HCC:G2
Boiling Pt:B.P. Text:NA
Melt/Freeze Pt:M.P/F.P Text:NA
Vapor Pres:NA
Vapor Density:NA
Spec Gravity:NA
pH:NA
Viscosity:NA
Evaporation Rate & Reference:NA
Solubility in Water:NA
Appearance and Odor:KENALOG SPRAY IS SUPPLIED IN A SPRAY CAN. THIS CAN
CONTAINS A FLAMMABLE GAS.
Percent Volatiles by Volume:NA

Stability

Stability Indicator/Materials to Avoid:YES
KEEP SEPERATE FROM OXIDIZING AGENTS.
Stability Condition to Avoid:HIGH HEAT, OPEN FLAMES AND OTHER SOURCES
OF IGNITION.
Hazardous Decomposition Products:THERMAL DECOMPOSITION/BURNING MAY
PRODUCE NOXIOUS PRODUCTS INCLUDING: CARBON MONOXIDE, CARBON
DIOXIDE, HYDROGEN FLUORIDE
Conditions to Avoid Polymerization:WILL NOT OCCUR.

Disposal

Waste Disposal Methods:DISPOSE OF IN ACCORDANCE WITH ALL LOCAL, STATE
AND FEDERAL REGULATIONS OR WITH THE REGULATIONS OF THE COUNTRY IN
WHICH THE MATERIAL IS USED.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.